Peruzzi D - Search Results

1

A novel chimpanzee serotype-based adenoviral vector as delivery tool for cancer vaccines.

Peruzzi D, Dharmapuri S, Cirillo A, Bruni BE, Nicosia A, Cortese R, Colloca S, Ciliberto G, La Monica N, Aurisicchio L. Peruzzi D, et al. Vaccine. 2009 Feb 25;27(9):1293-300. doi: 10.1016/j.vaccine.2008.12.051. Epub 2009 Jan 20. Vaccine. 2009. PMID: 19162112 Free PMC article.

2

A therapeutic cancer vaccine targeting carcinoembryonic antigen in intestinal carcinomas.

Mori F, Giannetti P, Peruzzi D, Lazzaro D, Giampaoli S, Kaufman HL, Ciliberto G, La Monica N, Aurisicchio L. Mori F, et al. Among authors: peruzzi d. Hum Gene Ther. 2009 Feb;20(2):125-36. doi: 10.1089/hum.2008.116. Hum Gene Ther. 2009. PMID: 18937552

3

A novel mouse model for evaluation and prediction of HLA-A2-restricted CEA cancer vaccine responses.

Conforti A, Peruzzi D, Giannetti P, Biondo A, Ciliberto G, La Monica N, Aurisicchio L. Conforti A, et al. Among authors: peruzzi d. J Immunother. 2009 Sep;32(7):744-54. doi: 10.1097/CJI.0b013e3181aee1b6. J Immunother. 2009. PMID: 19561534

4

Engineered adenovirus serotypes for overcoming anti-vector immunity.

Dharmapuri S, Peruzzi D, Aurisicchio L. Dharmapuri S, et al. Among authors: peruzzi d. Expert Opin Biol Ther. 2009 Oct;9(10):1279-87. doi: 10.1517/14712590903187053. Expert Opin Biol Ther. 2009. PMID: 19645630 Review.

5

Telomerase and HER-2/neu as targets of genetic cancer vaccines in dogs.

Peruzzi D, Mesiti G, Ciliberto G, La Monica N, Aurisicchio L. Peruzzi D, et al. Vaccine. 2010 Feb 3;28(5):1201-8. doi: 10.1016/j.vaccine.2009.11.031. Epub 2009 Nov 26. Vaccine. 2010. PMID: 19944791

6

A TLR9 agonist enhances therapeutic effects of telomerase genetic vaccine.

Conforti A, Cipriani B, Peruzzi D, Dharmapuri S, Kandimalla ER, Agrawal S, Mori F, Ciliberto G, La Monica N, Aurisicchio L. Conforti A, et al. Among authors: peruzzi d. Vaccine. 2010 Apr 30;28(20):3522-30. doi: 10.1016/j.vaccine.2010.03.020. Epub 2010 Mar 21. Vaccine. 2010. PMID: 20332048

7

Immunogenicity and therapeutic efficacy of a dual-component genetic cancer vaccine cotargeting carcinoembryonic antigen and HER2/neu in preclinical models.

Aurisicchio L, Peruzzi D, Koo G, Wei WZ, La Monica N, Ciliberto G. Aurisicchio L, et al. Among authors: peruzzi d. Hum Gene Ther. 2014 Feb;25(2):121-31. doi: 10.1089/hum.2013.103. Epub 2013 Dec 21. Hum Gene Ther. 2014. PMID: 24195644 Free PMC article.

8

Intratumor RNA interference of cell cycle genes slows down tumor progression.

Dharmapuri S, Peruzzi D, Marra E, Palombo F, Bett AJ, Bartz SR, Yong M, Ciliberto G, La Monica N, Buser CA, Toniatti C, Aurisicchio L. Dharmapuri S, et al. Among authors: peruzzi d. Gene Ther. 2011 Jul;18(7):727-33. doi: 10.1038/gt.2011.27. Epub 2011 Mar 10. Gene Ther. 2011. PMID: 21390070

9

Treatment of mammary carcinomas in HER-2 transgenic mice through combination of genetic vaccine and an agonist of Toll-like receptor 9.

Aurisicchio L, Peruzzi D, Conforti A, Dharmapuri S, Biondo A, Giampaoli S, Fridman A, Bagchi A, Winkelmann CT, Gibson R, Kandimalla ER, Agrawal S, Ciliberto G, La Monica N. Aurisicchio L, et al. Among authors: peruzzi d. Clin Cancer Res. 2009 Mar 1;15(5):1575-84. doi: 10.1158/1078-0432.CCR-08-2628. Epub 2009 Feb 24. Clin Cancer Res. 2009. PMID: 19240169

10

MMP11: a novel target antigen for cancer immunotherapy.

Peruzzi D, Mori F, Conforti A, Lazzaro D, De Rinaldis E, Ciliberto G, La Monica N, Aurisicchio L. Peruzzi D, et al. Clin Cancer Res. 2009 Jun 15;15(12):4104-13. doi: 10.1158/1078-0432.CCR-08-3226. Epub 2009 Jun 9. Clin Cancer Res. 2009. PMID: 19509157

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

36 results

Search Page

Filters